Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.665 USD | -0.93% | -2.19% | -34.47% |
13/05 | Morgan Stanley Lowers Price Target on Organogenesis Holdings to $3 From $3.50, Keeps Equalweight Rating | MT |
10/05 | Health Care Edges Higher Amid Rotation to Utilities - Health Care Roundup | DJ |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.47% | 357M | |
+69.56% | 62.86B | |
-0.64% | 41.38B | |
+45.66% | 40.38B | |
-10.72% | 27.64B | |
+14.73% | 26.46B | |
-22.22% | 18.9B | |
+4.87% | 12.67B | |
+23.92% | 12.27B | |
+28.11% | 12.07B |
- Stock Market
- Equities
- ORGO Stock
- News Organogenesis Holdings Inc.
- Transcript : Organogenesis Holdings Inc. Presents at Morgan Stanley 19th Annual Global Healthcare Conference, Sep-14-2021 01